http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ae427f8174deba3d9c25c587985f62a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | González |
| name | Arantxa González |
| given-name | Arantxa |
| organization-name | Program of Cardiovascular Diseases, Center for Applied Medical Research, University of Navarra, Avda/ Pío XII 55, 31008, Pamplona, Spain; CIBERCV, National Institute of Health Carlos III, C/ Monforte de Lemos 3-5, 28029, Madrid, Spain Division of Cardiovascular Sciences, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain Program of Cardiovascular Diseases Centre for Applied Medical Research University of Navarra Pamplona Spain; IdiSNA Navarra Institute for Health Research Pamplona Spain; CIBERCV Carlos III Institute of Health Madrid Spain Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA Pamplona Spain; CIBERCV, Carlos III Institute of Health Madrid Spain From the Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands (N.H., C.F., C.A.O., W.J.P.); Department of Cardiovascular Physiology, Ruhr University Bochum, Bochum, Germany (N.H., L.P., W.A.L.); Department of Physiology and Cardiothoracic Surgery, University of Porto, Porto, Portugal (A.L., I.F.-P., D.F., S.L., A.F.L.-M.); Division of Cardiovascular Sciences, Centre for Applied Medical Research, University of Navarra, Pamplona,... Division of Cardiovascular Sciences, Centre for Applied Medical Research, University of Navarra, Avda. Pío XII 55, 31008 Pamplona, Spain Division of Cardiovascular Pathophysiology, Centre for Applied Medical Research, School of Medicine, University of Navarra, Pamplona, Spain. Division of Cardiovascular Sciences, Centre for Applied Medical Research, University of Navarra, Pamplona; From the Division of Cardiovascular Sciences, Centre for Applied Medical Research (B.L., A.G., J.D.), and Department of Cardiology and Cardiac Surgery, University of Navarra Clinic (JD), University of Navarra, Pamplona, Spain; Division of Cardiology (M.L., R.Q.), Donostia University Hospital, San Sebastián, Spain. From the Program of Cardiovascular Diseases, Center for Applied Medical Research, University of Navarra, Pamplona, Spain (A.G., S.R., B.L., M.U.M., J.B., G.S.J., J.D.); Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain (A.G., S.R., B.L., M.U.M., J.B., G.S.J., J.D.); CIBERCV, Carlos III Institute of Health, Madrid, Spain (A.G., S.R., B.L., M.U.M., J.B., G.S.J., A.B.-G., J.D.) From the Cardiovascular Division (C.Y.H., S.A.A., T.G.N., R.V.S., Y.C., B.H., A.L.C., N.K.L., R.Y.K.), Brigham and Women’s Hospital (M.J.-H.), Boston, MA; and Division of Cardiovascular Sciences, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain (A.G., B.L., J.D.). University of Navarra, CIMA, Program of Cardiovascular Diseases, IdiSNA, Navarra Institute for Health Research Pamplona, Spain, CIBERCV, Carlos III Institute of Health Madrid Spain Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain (B.L., S.R., M.U.M., A.G., J.D.); CIBERCV, Carlos III Institute of Health, Madrid, Spain (B.L., S.R., M.U.M., A.G., J.D.); Instituto de Investigación Sanitaria de Navarra (IdiSNA), Spain (B.L., S.R., M.U.M., A.G., J.D.) Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona 31008, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona 31008, Spain Division of Cardiovascular Sciences, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain. Centre for Applied Medical Research (CIMA), Department of Cardiology and Cardiac SurgeryUniversity of NavarraPamplonaSpain CIBERCV Instituto de Salud Carlos III Madrid Spain; Program of Cardiovascular Diseases CIMA Universidad de Navarra, and Navarra Institute for Health Research (IdiSNA) Pamplona Spain Program of Cardiovascular Diseases CIMA Universidad de Navarra Pamplona Spain; CIBERCV Carlos III Institute of Health Madrid Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA) Pamplona Spain CIMA Universidad de Navarra, and IdiSNA Navarra Institute for Health Research Pamplona Spain; CIBERCV, Carlos III Institute of Health Madrid Spain Tissue Microenvironment (TME) Lab, Aragón Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza 50018, Spain; Program of Cardiovascular Diseases, CIMA Universidad de Navarra, and Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona 31008, Spain; CIBERCV, Instituto de Salud Carlos III, Madrid 28029, Spain Program of Cardiovascular Diseases CIMA Universidad de Navarra and IdiSNA Pamplona Spain; CIBERCV Carlos III Institute of Health Madrid Spain Program of Cardiovascular Diseases, CIMA Universidad de Navarra, IdiSNA and CIBERCV Pamplona Spain IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program of Cardiovascular Diseases, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain Program of Cardiovascular Diseases, Centre for Applied Medical Research University of Navarra Pamplona Spain Program of Cardiovascular Diseases, Center for Applied Medical Research‐FIMA University of Navarra Pamplona Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA) Pamplona Spain Program of Cardiovascular Diseases, Center for Applied Medical Research, University of Navarra IdiSNA, Navarra Institute for Health Research, CIBERCV, Carlos III Institute of Health Madrid Spain Program of Cardiovascular Diseases, CIMA Universidad de Navarra, Pamplona, Spain; Institute of Medical Research of Navarra, IDISNA, Pamplona, Spain; Center of Network Biomedical Research in Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health, Madrid, Spain Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona and CIBERCV, Carlos III Institute of Health, Madrid, Spain Division of Cardiovascular Sciences, Centre for Applied Medical Research, University of Navarra, 31008 Pamplona, Spain Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain (J.D., A.G.).; CIBERCV, Carlos III Institute of Health, Madrid, Spain (J.D., A.G.).; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Spain (J.D., A.G.). CIBERCV, Carlos III Institute of Health Madrid Spain; Program of Cardiovascular Diseases CIMA Universidad de Navarra and IdiSNA, Navarra Institute for Health Research Pamplona Spain Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain (G.S.J., J.B., B.L., S.R., J.D., A.G.).; CIBERCV, Institute of Health Carlos III, Madrid, Spain (G.S.J., J.B., B.L., S.R., J.D., A.G.). Program of Cardiovascular Diseases, Center for Applied Medical Research University of Navarra Pamplona Spain Program of Cardiovascular Diseases, CIMA University of Navarra and IdiSNA, Pamplona. Spain (C.B., S.R., B.L., M.U.M., J.D., A.G.); CIBERCV, Carlos III Institute of Health, Madrid. Spain (S.R., B.L., M.U.M., J.D., A.G.) Program of Cardiovascular Diseases, Center for Applied Medical Research University of Navarra Pamplona Spain; Department of Cardiology and Cardiac Surgery University of Navarra Clinic Pamplona Spain; CIBERCV, Institute of Health Carlos III Madrid Spain Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA Pamplona Spain; CIBERCV, Carlos III Institute of Health Madrid Spain Program of Cardiovascular Diseases, CIMA Universidad de Navarra, and IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; CIBERCV, Carlos III Institute of Health Madrid Spain Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA Madrid Spain Program of Cardiovascular Diseases, CIMA Universidad de Navarra IdiSNA and CIBERCV Pamplona Spain From the Department of Cardiology (R.V., T.P., R.v.L., W.V., M.H., L.J.d.W., S.H., B.S.), Department of Physiology (C.M., F.A.v.N., M.v.B.), and Department of Internal Medicine (M.B.), CARIM School for Cardiovascular Diseases, Maastricht University, The Netherlands; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain (F.J.B., J.D., A.G.); Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (F.J.B., J.D., A.G.); CIBERCV... Program of Cardiovascular Diseases, CIMA Universidad de Navarra, IdiSNA and CIBERCV, Pamplona, Navarra, Spain CIBER Cardiovascular Madrid Spain; Program of Cardiovascular Diseases, CIMA Universidad de Navarra, Pamplona, Spain; IdiSNA Navarra Institute for Health Research Pamplona Spain Program of Cardiovascular Diseases, Center for Applied Medical Research (CIMA) Universidad de Navarra Pamplona Spain; IdiSNA Navarra Institute for Health Research Pamplona Spain; CIBERCV Carlos III Institute of Health Madrid Spain Program of Cardiovascular Diseases CIMA Universidad de Navarra, and IdiSNA, Navarra Institute for Health Research Pamplona Spain; CIBERCV Carlos III Institute of Health Madrid Spain Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain (A.G., J.D.); Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Carlos III Institute of Health, Madrid, Spain (A.G., J.D.); Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (N.G.-F., J.M., A.G., J.D.). Program of Cardiovascular Diseases, CIMA. Universidad de Navarra and IdiSNA, Pamplona, Spain CIBERCV, Carlos III Institute of Health , Madrid, Spain Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, 31008 Pamplona, Spain; CIBERCV, Carlos III Institute of Health, 28029 Madrid, Spain Program of Cardiovascular Diseases, Centre for Applied Medical University of Navarra and IdisNA, Pamplona Spain; CIBERCV Carlos III Institute of Health Madrid Spain; Departments of Cardiology and Cardiac Surgery and of Nephrology University of Navarra Clinic Pamplona Spain Division of Cardiovascular Sciences University of Navarra Pamplona Spain From the Division of Cardiovascular Sciences, Centre for Applied Medical Research (B.L., A.G., J.D.) and Department of Cardiology and Cardiac Surgery, University of Navarra Clinic (G.R., J.D.), University of Navarra, Pamplona, Spain; and Division of Cardiology, Donostia University Hospital, San Sebastián, Spain (R.Q., M.L.). Division of Cardiovascular Pathophysiology, School of Medicine, and Department of Cardiology and Cardiovascular Surgery, University Clinic, University of Navarra, Pamplona, Spain. Division of Cardiovascular Pathophysiology, Centre for Applied Medical Research, and Program of Cardiovascular Diseases CIMA Universidad de Navarra and IdiSNA Pamplona Spain; CIBERCV, Carlos III Institute of Health Madrid Spain |
Incoming Links
Total number of triples: 190.